Generic placeholder image

Current Drug Delivery

Eiditor-in-Chief

ISSN (Print): 1567-2018
ISSN (Online): 1875-5704

Review Article

Emerging Trends On Drug Delivery Strategy of Momordica charantia against Diabetes and its Complications

Author(s): Zar Chi Thent*, Srijit Das and Nurul Hannim Zaidun

Volume 15 , Issue 4 , 2018

Page: [453 - 460] Pages: 8

DOI: 10.2174/1567201814666170525122224

Price: $58

Abstract

Background: The incidence of diabetes mellitus has increased drastically over the past few decades. This oxidant-antioxidant imbalance resulting in complication of diabetes mellitus includes macro- and microvascular complications. Resistance to conventional treatment and patient compliance has paved the way to the usage of effective natural products and supplements. Momordica charantia (bitter gourd) is widely consumed in many parts of Malaysia as a vegetable. Momordica charantia (MC) is mainly used in the management of diabetes mellitus.

Objective: The present review discusses the literature concerning the antidiabetic and antioxidant properties of MC focusing on the complication of diabetes mellitus along with its mode of delivery. We found that among the whole part of MC, its fruit extract has been widely studied, therapeutically. The evidence based analysis of the beneficiary effects of MC on the different organs involved in diabetes complication is also highlighted. This review elucidated an essential understanding of MC based drug delivery system in both clinical and experimental studies and appraised the great potential of the protein based MC extract against diabetes mellitus.

Conclusion: The review paper is believed to assist the researchers and medical personnel in treating diabetic associated complications.

Keywords: Antioxidant, complications, diabetes mellitus, drug delivery, Momordica charantia, oxidant.

Graphical Abstract

Rights & Permissions Print Export Cite as
Article Metrics
31
7
2
3
Related Journals
Related eBooks
Related Articles
© 2019 Bentham Science Publishers